Beaconcure, Inc., a leader in trusted clinical data quality control and validation solutions for clinical development, today announced Verify has been named “QC Data Management Solution of the Year” in the sixth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.

Verify is a built for purpose cloud-based SaaS platform that protects clinical trial submissions from errors. The AI-enabled statistical analysis and validation platform replaces fragmented, manual Quality Control (QC) processes with a centralized, automated, and traceable approach. Biometrics teams benefit from a single environment to review Tables, Listings, and Figures (TLFs), execute automated validation checks, manage findings, track review activity, and maintain oversight across studies.

The platform can automatically perform checks across clinical outputs, including consistency and alignment checks, titles and footnotes, arithmetic, reference conformance, and other validation activities. Potential discrepancies are surfaced for expert assessment review by biometrics professionals. Verify also centralizes the review workflow itself. Beaconcure’s approach is designed around human expertise. Verify does not make scientific decisions on behalf of clinical teams. Instead, automation and AI perform repeatable validation activities while qualified professionals retain responsibility for review, interpretation, and approval.

Teams can collaborate, document findings and resolutions, and maintain a traceable activity history within the same environment. Dashboards and tracking provide visibility across studies and portfolios, helping organizations move from document-level QC toward systematic quality oversight. The platform also provides an additional layer of independence through AI-generated validation tables. Using ADaM datasets and study documentation such as Statistical Analysis Plans, shells, and specifications, Verify can independently generate validation tables and compare them against production outputs.

“Thank you so much to BioTech Breakthrough for the ‘QC Data Management Solution of the Year’ award. By bringing automated QC, independent validation, collaboration, traceability, and governance into one connected platform, we are helping organizations rethink a process that has remained largely manual for decades,” said Seth Houston, CEO of Beaconcure. “With Verify, biometrics teams can reduce the validation bottleneck without compromising confidence, helping them accelerate QC while maintaining the independence and rigor required for clinical trials. Greater visibility and control from validation through resolution means more life-saving advances coming to market sooner.”

The life sciences and biotechnology sector is rapidly redefining how diseases are discovered, diagnosed and treated, transforming one of the world’s most critical industries. From genomics and gene editing to AI-powered drug discovery, cell and gene therapies, and advanced bioprocessing, biotechnology is delivering faster breakthroughs, more personalized care and better outcomes for patients around the world.

The mission of the annual BioTech Breakthrough Awards program is to recognize the innovators transforming the global biotechnology and life sciences landscape with breakthrough technology. The program conducts a comprehensive analysis of the companies redefining how therapies are researched, developed, manufactured and delivered. From AI-driven drug discovery platforms and precision medicine to synthetic biology, bioinformatics, and next-generation diagnostics and biomanufacturing, these innovations are enabling life sciences organizations to accelerate research, reduce development costs, bring life-changing treatments to market faster, and shape the future of human health.

“Beaconcure is modernizing how life sciences organizations manage QC across clinical statistical analysis and reporting. Traditional statistical QC is often distributed across documents, email, programming environments, and manual review. This makes it difficult to understand what has been reviewed, identify unresolved issues, maintain consistency across teams, and show a complete history of validation activity,” said Bryan Vaughn, Managing Director, BioTech Breakthrough. “Verify turns those individual QC activities into a governed quality process. Beaconcure transforms QC from a downstream checkpoint into a continuous, technology-enabled quality framework, giving clinical teams greater visibility and control while enabling statistical validation to operate at the speed and scale of modern drug development.”

About Beaconcure

Beaconcure empowers biopharmaceutical companies and CROs to modernize clinical development through trusted AI solutions for validation, quality, and regulatory workflows. The company’s Verify platform enables teams to review, validate, and govern clinical analyses with greater efficiency, transparency, and confidence while maintaining the quality and compliance required for regulated environments.

To learn more about Beaconcure’s platform and how it is helping life sciences organizations modernize clinical development, visit www.beaconcure.com.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Media gallery

About The Author
Business Wire